[HTML][HTML] Genetic testing in neurodevelopmental disorders
Neurodevelopmental disorders are the most prevalent chronic medical conditions
encountered in pediatric primary care. In addition to identifying appropriate descriptive …
encountered in pediatric primary care. In addition to identifying appropriate descriptive …
The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy
Arrhythmogenic cardiomyopathy (ACM) is a heritable cardiomyopathy characterized by
frequent ventricular arrhythmias and progressive ventricular dysfunction. Risk of sudden …
frequent ventricular arrhythmias and progressive ventricular dysfunction. Risk of sudden …
[HTML][HTML] 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest …
MK Stiles, AAM Wilde, DJ Abrams, MJ Ackerman… - Heart Rhythm, 2021 - Elsevier
This international multidisciplinary document intends to provide clinicians with evidence-
based practical patient-centered recommendations for evaluating patients and decedents …
based practical patient-centered recommendations for evaluating patients and decedents …
Opportunistic genomic screening. Recommendations of the European society of human genetics
G de Wert, W Dondorp, A Clarke… - European Journal of …, 2021 - nature.com
If genome sequencing is performed in health care, in theory the opportunity arises to take a
further look at the data: opportunistic genomic screening (OGS). The European Society of …
further look at the data: opportunistic genomic screening (OGS). The European Society of …
From genetics to genomics: facing the liability implications in clinical care
G Marchant, M Barnes, JP Evans, B LeRoy… - Journal of Law …, 2020 - cambridge.org
Health care is transitioning from genetics to genomics, in which single-gene testing for
diagnosis is being replaced by multi-gene panels, genome-wide sequencing, and other …
diagnosis is being replaced by multi-gene panels, genome-wide sequencing, and other …
[PDF][PDF] The responsibility to recontact research participants after reinterpretation of genetic and genomic research results
Y Bombard, KB Brothers, S Fitzgerald-Butt… - The American Journal of …, 2019 - cell.com
The evidence base supporting genetic and genomic sequence-variant interpretations is
continuously evolving. An inherent consequence is that a variant's clinical significance might …
continuously evolving. An inherent consequence is that a variant's clinical significance might …
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics …
H Hanson, E Astiazaran-Symonds, LM Amendola… - Genetics in …, 2023 - Elsevier
Purpose Although the role of CHEK2 germline pathogenic variants in cancer predisposition
is well known, resources for managing CHEK2 heterozygotes in clinical practice are limited …
is well known, resources for managing CHEK2 heterozygotes in clinical practice are limited …
Is there a duty to reinterpret genetic data? The ethical dimensions
The evolving evidence base for the interpretation of variants identified in genetic and
genomic testing has presented the genetics community with the challenge of variant …
genomic testing has presented the genetics community with the challenge of variant …
Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms
There are several key unsolved issues relating to the clinical use of next generation
sequencing, such as: should laboratories report variants of uncertain significance (VUS) to …
sequencing, such as: should laboratories report variants of uncertain significance (VUS) to …
[HTML][HTML] Variant classification changes over time in BRCA1 and BRCA2
Purpose To report BRCA1 and BRCA2 (BRCA1/2) variant reassessments and
reclassifications between 2012 and 2017 at the Advanced Molecular Diagnostics Laboratory …
reclassifications between 2012 and 2017 at the Advanced Molecular Diagnostics Laboratory …